The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...

President Donald Trump’s announcement about tariffs on pharmaceutical goods imported to the United States is delayed. | ...

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

Lauren Roche shares her extraordinary story of survival, strength and reinvention from a troubled youth to a published ...

Already USFDA-approved, under-the-skin jab can be administered in just seven minutes to the patient. This is dramatic cut ...

Swiss pharma company prints 4.75, 10 and 15 year bonds ◆ Deal size increased to Sfr775m on strong demand ◆ Spreads land 2bp ...

With its domination of the indication- and brand-specific analyses, it should come as no surprise that AstraZeneca led the ...

New data show that the new CDK4/6 inhibitor with fulvestrant yields a notable PFS benefit in HR+/HER2- advanced breast cancer ...

The clean-up bill for Swiss pharma giant Roche's former Co Clare manufacturing site now totals €150.5m in what the company describes as "one of the largest remediation projects of its type in Europe".

Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...

A primary school teacher who defrauded three colleagues out of over €2,000 in "an elaborate hoax" and failed to repay a ...